Search

Search Results
Results 3521 - 3530 of 5746 for addiction
  • Health - 7 Aug 2023
    Epigenetics has emerged as a key player in the development and severity of type 2 diabetes.
  • Health - 21 Jul 2023
    Cannabinoid hyperemesis syndrome (CHS) is a rare condition which mainly develops due to a prolonged use of marijuana (cannabis). It is associated with acute episodes of vomiting and nausea which do...
  • Health - 9 Sep 2022
    Behavioral medicine integrates behavioral, psychosocial, and biomedical concepts to prevent, diagnose, and treat patients with psychosomatic disorders.
  • Health - 18 Jun 2019
    Intermittent or middle-of-the-night Insomnia afflicts 10-40% of adults in the US population. It is characterized by nocturnal awakenings with difficulty in returning to sleep afterwards.
  • Health - 26 Feb 2019
    Insomnia is a common condition which causes emotional and physical stress, and is also responsible for many workday losses and decreased productivity. The management of insomnia starts with taking a...
  • Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about DBL Fentanyl Injection intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Paracetamol/Codeine GH 500/30 intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Panadeine Forte intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Comfarol Forte intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.